{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:11:10Z","timestamp":1793121070562,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T00:00:00Z","timestamp":1654819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T00:00:00Z","timestamp":1654819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006484","name":"Vifor Pharma","doi-asserted-by":"publisher","award":["TPL107"],"award-info":[{"award-number":["TPL107"]}],"id":[{"id":"10.13039\/501100006484","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006484","name":"Vifor Pharma","doi-asserted-by":"publisher","award":["TPL107"],"award-info":[{"award-number":["TPL107"]}],"id":[{"id":"10.13039\/501100006484","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006484","name":"Vifor Pharma","doi-asserted-by":"publisher","award":["TPL107"],"award-info":[{"award-number":["TPL107"]}],"id":[{"id":"10.13039\/501100006484","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007210","name":"RWTH Aachen University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007210","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hyperphosphatemia is a consequence of chronic kidney disease associated with mineral\/bone impairment, increased cardiovascular events and mortality. Therapeutically, most dialysis patients have to take phosphate binders. Here, we investigated effects of the Fe(3+)-based phosphate binder sucroferric oxyhydroxide (SFOH) on the oral and gastrointestinal microbiome of 11 hemodialysis patients. Saliva, dental plaque and stool were collected at baseline, one and four weeks of SFOH intake and subjected to 16S rRNA gene (V3-V4 region) directed Illumina MiSeq-based analysis. Total Fe, Fe(2+) and Fe(3+) were determined in stool and saliva. Overall, the microbiome did not change significantly. However, some patient-, sample- and taxon-specific differences were noted, which allowed patients to be divided into those with a shift in their microbiome (6\/11) and those without a shift (5\/11). Total Fe and Fe(2+) were highest after one week of SFOH, particularly in patients who exhibited a shift in microbiome composition. Eight bacterial taxa showed significant unidirectional changes during treatment. In-depth microbiome analysis revealed that taxa that significantly benefited from iron plethora had no iron-binding siderophores or alternatives, which was in contrast to taxa that significantly declined under iron plethora. Patients with microbiome-shift were significantly younger and had higher serum phosphate concentrations. In conclusion, this study sheds light on the impact of iron on the microbiome of hemodialysis patients.<\/jats:p>","DOI":"10.1038\/s41598-022-13552-z","type":"journal-article","created":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T15:04:08Z","timestamp":1654873448000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Impact of sucroferric oxyhydroxide on the oral and intestinal microbiome in hemodialysis patients"],"prefix":"10.1038","volume":"12","author":[{"given":"Mohamed M. H.","family":"Abdelbary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Kuppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sareh Said-Yekta","family":"Michael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thilo","family":"Kr\u00fcger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Floege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Conrads","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,10]]},"reference":[{"key":"13552_CR1","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/ki.2014.58","volume":"86","author":"J Floege","year":"2014","unstructured":"Floege, J. et al. A phase III study of the efficacy and safety of a novel iron-based phosphate binder in dialysis patients. Kidney Int. 86, 638\u2013647. https:\/\/doi.org\/10.1038\/ki.2014.58 (2014).","journal-title":"Kidney Int."},{"key":"13552_CR2","doi-asserted-by":"publisher","first-page":"251","DOI":"10.5414\/cn108119","volume":"81","author":"M Wilhelm","year":"2014","unstructured":"Wilhelm, M., Gaillard, S., Rakov, V. & Funk, F. The iron-based phosphate binder PA21 has potent phosphate binding capacity and minimal iron release across a physiological pH range in vitro. Clin. Nephrol. 81, 251\u2013258. https:\/\/doi.org\/10.5414\/cn108119 (2014).","journal-title":"Clin. Nephrol."},{"key":"13552_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.5414\/cnp74004","volume":"74","author":"P Geisser","year":"2010","unstructured":"Geisser, P. & Philipp, E. PA21: A novel phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease. Clin. Nephrol. 74, 4\u201311. https:\/\/doi.org\/10.5414\/cnp74004 (2010).","journal-title":"Clin. Nephrol."},{"key":"13552_CR4","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1093\/ndt\/14.4.863","volume":"14","author":"O Hergesell","year":"1999","unstructured":"Hergesell, O. & Ritz, E. Stabilized polynuclear iron hydroxide is an efficient oral phosphate binder in uraemic patients. Nephrol. Dial. Transplant 14, 863\u2013867. https:\/\/doi.org\/10.1093\/ndt\/14.4.863 (1999).","journal-title":"Nephrol. Dial. Transplant"},{"key":"13552_CR5","doi-asserted-by":"publisher","first-page":"280","DOI":"10.2215\/CJN.08230811","volume":"8","author":"RP Wuthrich","year":"2013","unstructured":"Wuthrich, R. P. et al. Randomized clinical trial of the iron-based phosphate binder PA21 in hemodialysis patients. Clin. J. Am. Soc. Nephrol. 8, 280\u2013289. https:\/\/doi.org\/10.2215\/CJN.08230811 (2013).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"13552_CR6","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s10157-020-01892-x","volume":"24","author":"A Iguchi","year":"2020","unstructured":"Iguchi, A. et al. Effect of sucroferric oxyhydroxide on gastrointestinal microbiome and uremic toxins in patients with chronic kidney disease undergoing hemodialysis. Clin Exp Nephrol 24, 725\u2013733. https:\/\/doi.org\/10.1007\/s10157-020-01892-x (2020).","journal-title":"Clin Exp Nephrol"},{"key":"13552_CR7","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-021-03091-3","author":"A Merino-Ribas","year":"2021","unstructured":"Merino-Ribas, A. et al. Gut microbiome in hemodialysis patients treated with calcium acetate or treated with sucroferric oxyhydroxide: A pilot study. Int. Urol. Nephrol. https:\/\/doi.org\/10.1007\/s11255-021-03091-3 (2021).","journal-title":"Int. Urol. Nephrol."},{"key":"13552_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/nu13072269","author":"A Mahalhal","year":"2021","unstructured":"Mahalhal, A. et al. Oral ferric maltol does not adversely affect the intestinal microbiome of patients or mice, but ferrous sulphate does. Nutrients https:\/\/doi.org\/10.3390\/nu13072269 (2021).","journal-title":"Nutrients"},{"key":"13552_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10534-008-9199-7","volume":"22","author":"V Braun","year":"2009","unstructured":"Braun, V., Pramanik, A., Gwinner, T., Koberle, M. & Bohn, E. Sideromycins: Tools and antibiotics. Biometals 22, 3\u201313. https:\/\/doi.org\/10.1007\/s10534-008-9199-7 (2009).","journal-title":"Biometals"},{"key":"13552_CR10","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/bs.ampbs.2017.01.002","volume":"70","author":"AG Turner","year":"2017","unstructured":"Turner, A. G., Ong, C. Y., Walker, M. J., Djoko, K. Y. & McEwan, A. G. Transition metal homeostasis in Streptococcus pyogenes and Streptococcus pneumoniae. Adv. Microb. Physiol. 70, 123\u2013191. https:\/\/doi.org\/10.1016\/bs.ampbs.2017.01.002 (2017).","journal-title":"Adv. Microb. Physiol."},{"key":"13552_CR11","doi-asserted-by":"publisher","DOI":"10.1128\/JB.00014-19","author":"JE Scott","year":"2019","unstructured":"Scott, J. E. et al. Pseudomonas aeruginosa can inhibit growth of streptococcal species via siderophore production. J. Bacteriol. https:\/\/doi.org\/10.1128\/JB.00014-19 (2019).","journal-title":"J. Bacteriol."},{"key":"13552_CR12","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.02412-16","author":"J Zhou","year":"2017","unstructured":"Zhou, J. et al. Influences of pH and iron concentration on the salivary microbiome in individual humans with and without caries. Appl. Environ. Microbiol. https:\/\/doi.org\/10.1128\/AEM.02412-16 (2017).","journal-title":"Appl. Environ. Microbiol."},{"key":"13552_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0146926","volume":"11","author":"SR Vartoukian","year":"2016","unstructured":"Vartoukian, S. R. et al. In vitro cultivation of \u201cunculturable\u201d oral bacteria, facilitated by community culture and media supplementation with siderophores. PLoS ONE 11, e0146926. https:\/\/doi.org\/10.1371\/journal.pone.0146926 (2016).","journal-title":"PLoS ONE"},{"key":"13552_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8122040","author":"PH Wu","year":"2020","unstructured":"Wu, P. H. et al. Comparative gut microbiome differences between ferric citrate and calcium carbonate phosphate binders in patients with end-stage kidney disease. Microorganisms https:\/\/doi.org\/10.3390\/microorganisms8122040 (2020).","journal-title":"Microorganisms"},{"key":"13552_CR15","doi-asserted-by":"publisher","first-page":"5861","DOI":"10.1038\/s41598-017-06221-z","volume":"7","author":"L Eriksson","year":"2017","unstructured":"Eriksson, L., Lif Holgerson, P. & Johansson, I. Saliva and tooth biofilm bacterial microbiota in adolescents in a low caries community. Sci. Rep. 7, 5861. https:\/\/doi.org\/10.1038\/s41598-017-06221-z (2017).","journal-title":"Sci. Rep."},{"key":"13552_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12866-014-0334-z","volume":"15","author":"P Vazquez-Gutierrez","year":"2015","unstructured":"Vazquez-Gutierrez, P. et al. Bifidobacteria strains isolated from stools of iron deficient infants can efficiently sequester iron. BMC Microbiol. 15, 3. https:\/\/doi.org\/10.1186\/s12866-014-0334-z (2015).","journal-title":"BMC Microbiol."},{"key":"13552_CR17","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1128\/IAI.02042-14","volume":"83","author":"P Manfredi","year":"2015","unstructured":"Manfredi, P. et al. New iron acquisition system in Bacteroidetes. Infect. Immun. 83, 300\u2013310. https:\/\/doi.org\/10.1128\/IAI.02042-14 (2015).","journal-title":"Infect. Immun."},{"key":"13552_CR18","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/nsb0403-240","volume":"10","author":"A Butler","year":"2003","unstructured":"Butler, A. Iron acquisition: Straight up and on the rocks?. Nat. Struct. Biol. 10, 240\u2013241. https:\/\/doi.org\/10.1038\/nsb0403-240 (2003).","journal-title":"Nat. Struct. Biol."},{"key":"13552_CR19","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.anaerobe.2004.01.004","volume":"10","author":"K Holmstrom","year":"2004","unstructured":"Holmstrom, K., Collins, M. D., Moller, T., Falsen, E. & Lawson, P. A. Subdoligranulum variabile gen. nov., sp. nov. from human feces. Anaerobe 10, 197\u2013203. https:\/\/doi.org\/10.1016\/j.anaerobe.2004.01.004 (2004).","journal-title":"Anaerobe"},{"key":"13552_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.trsl.2020.03.012","volume":"221","author":"DA Piggott","year":"2020","unstructured":"Piggott, D. A. & Tuddenham, S. The gut microbiome and frailty. Transl. Res. 221, 23\u201343. https:\/\/doi.org\/10.1016\/j.trsl.2020.03.012 (2020).","journal-title":"Transl. Res."},{"key":"13552_CR21","unstructured":"Di Iorio, B. R. et al. Urea and impairment of the gut-kidney axis in chronic kidney disease. G. Ital. Nefrol. 34 (2017)."},{"key":"13552_CR22","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1053\/j.ackd.2019.01.004","volume":"26","author":"M Syed-Ahmed","year":"2019","unstructured":"Syed-Ahmed, M. & Narayanan, M. Immune dysfunction and risk of infection in chronic kidney disease. Adv. Chronic. Kidney Dis. 26, 8\u201315. https:\/\/doi.org\/10.1053\/j.ackd.2019.01.004 (2019).","journal-title":"Adv. Chronic. Kidney Dis."},{"key":"13552_CR23","doi-asserted-by":"publisher","first-page":"3985","DOI":"10.1113\/jphysiol.2014.273979","volume":"592","author":"E Lederer","year":"2014","unstructured":"Lederer, E. Regulation of serum phosphate. J. Physiol. 592, 3985\u20133995. https:\/\/doi.org\/10.1113\/jphysiol.2014.273979 (2014).","journal-title":"J. Physiol."},{"key":"13552_CR24","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1111\/1574-6976.12086","volume":"38","author":"GA Kortman","year":"2014","unstructured":"Kortman, G. A., Raffatellu, M., Swinkels, D. W. & Tjalsma, H. Nutritional iron turned inside out: Intestinal stress from a gut microbial perspective. FEMS Microbiol. Rev. 38, 1202\u20131234. https:\/\/doi.org\/10.1111\/1574-6976.12086 (2014).","journal-title":"FEMS Microbiol. Rev."},{"key":"13552_CR25","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/1471-2180-11-212","volume":"11","author":"K Romanowski","year":"2011","unstructured":"Romanowski, K. et al. Prevention of siderophore- mediated gut-derived sepsis due to P. aeruginosa can be achieved without iron provision by maintaining local phosphate abundance: Role of pH. BMC Microbiol. 11, 212. https:\/\/doi.org\/10.1186\/1471-2180-11-212 (2011).","journal-title":"BMC Microbiol."},{"key":"13552_CR26","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1126\/science.1224577","volume":"338","author":"H Drakesmith","year":"2012","unstructured":"Drakesmith, H. & Prentice, A. M. Hepcidin and the iron-infection axis. Science 338, 768\u2013772. https:\/\/doi.org\/10.1126\/science.1224577 (2012).","journal-title":"Science"},{"key":"13552_CR27","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.chom.2020.06.004","volume":"28","author":"S Reitmeier","year":"2020","unstructured":"Reitmeier, S. et al. Arrhythmic gut microbiome signatures predict risk of type 2 diabetes. Cell Host Microbe 28, 258-272 e256. https:\/\/doi.org\/10.1016\/j.chom.2020.06.004 (2020).","journal-title":"Cell Host Microbe"},{"key":"13552_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2020.100148","volume":"1","author":"S Reitmeier","year":"2020","unstructured":"Reitmeier, S., Kiessling, S., Neuhaus, K. & Haller, D. Comparing circadian rhythmicity in the human gut microbiome. STAR Protoc. 1, 100148. https:\/\/doi.org\/10.1016\/j.xpro.2020.100148 (2020).","journal-title":"STAR Protoc."},{"key":"13552_CR29","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1128\/aem.63.7.2802-2813.1997","volume":"63","author":"JJ Godon","year":"1997","unstructured":"Godon, J. J., Zumstein, E., Dabert, P., Habouzit, F. & Moletta, R. Molecular microbial diversity of an anaerobic digestor as determined by small-subunit rDNA sequence analysis. Appl. Environ. Microbiol. 63, 2802\u20132813. https:\/\/doi.org\/10.1128\/aem.63.7.2802-2813.1997 (1997).","journal-title":"Appl. Environ. Microbiol."},{"key":"13552_CR30","doi-asserted-by":"publisher","first-page":"33721","DOI":"10.1038\/srep33721","volume":"6","author":"I Lagkouvardos","year":"2016","unstructured":"Lagkouvardos, I. et al. IMNGS: A comprehensive open resource of processed 16S rRNA microbial profiles for ecology and diversity studies. Sci. Rep. 6, 33721. https:\/\/doi.org\/10.1038\/srep33721 (2016).","journal-title":"Sci. Rep."},{"key":"13552_CR31","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/nmeth.2604","volume":"10","author":"RC Edgar","year":"2013","unstructured":"Edgar, R. C. UPARSE: Highly accurate OTU sequences from microbial amplicon reads. Nat. Methods 10, 996\u2013998. https:\/\/doi.org\/10.1038\/nmeth.2604 (2013).","journal-title":"Nat. Methods"},{"issue":"31","key":"13552_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s43705-021-00033-z","volume":"1","author":"S Reitmeier","year":"2021","unstructured":"Reitmeier, S. et al. Handling of spurious sequences affects the outcome of high-throughput 16S rRNA gene amplicon profiling. ISME Commun. 1(31), 1\u201312. https:\/\/doi.org\/10.1038\/s43705-021-00033-z (2021).","journal-title":"ISME Commun."},{"key":"13552_CR33","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.2836","volume":"5","author":"I Lagkouvardos","year":"2017","unstructured":"Lagkouvardos, I., Fischer, S., Kumar, N. & Clavel, T. Rhea: A transparent and modular R pipeline for microbial profiling based on 16S rRNA gene amplicons. PeerJ 5, e2836. https:\/\/doi.org\/10.7717\/peerj.2836 (2017).","journal-title":"PeerJ"},{"key":"13552_CR34","doi-asserted-by":"publisher","DOI":"10.1093\/femsec\/fiaa255","author":"C Liu","year":"2021","unstructured":"Liu, C., Cui, Y., Li, X. & Yao, M. microeco: An R package for data mining in microbial community ecology. FEMS Microbiol. Ecol. https:\/\/doi.org\/10.1093\/femsec\/fiaa255 (2021).","journal-title":"FEMS Microbiol. Ecol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13552-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13552-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13552-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T04:16:40Z","timestamp":1669349800000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13552-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,10]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["13552"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-13552-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,10]]},"assertion":[{"value":"27 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no Competing Non-Financial Interests but the following Competing Financial Interests. This is an investigator initiated clinical study but financially supported by Vifor Fresenius Medical Care Renal Pharma Ltd. Author J.F. has received lecture and consulting fees from Vifor Fresenius Medical Care Renal Pharma Ltd. All other authors (M.M.H.A., C.K., S.S-Y.M., T.K., and G.C.) have otherwise nothing to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9614"}}